Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges
- 1 September 2017
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 50 (3) , 287-302
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- A Multifunctional Protease Inhibitor To Regulate Endolysosomal FunctionACS Chemical Biology, 2011
- Enone– and Chalcone–Chloroquinoline Hybrid Analogues: In Silico Guided Design, Synthesis, Antiplasmodial Activity, in Vitro Metabolism, and Mechanistic StudiesJournal of Medicinal Chemistry, 2011
- Synthesis of New (−)-Bestatin-Based Inhibitor Libraries Reveals a Novel Binding Mode in the S1 Pocket of the Essential Malaria M1 MetalloaminopeptidaseJournal of Medicinal Chemistry, 2011
- Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1Molecular and Biochemical Parasitology, 2011
- Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitutionBioorganic & Medicinal Chemistry Letters, 2010
- Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarialsTrends in Biochemical Sciences, 2010
- Potent, Plasmodium-Selective Farnesyltransferase Inhibitors That Arrest the Growth of Malaria Parasites: Structure−Activity Relationships of Ethylenediamine-Analogue Scaffolds and Homology Model ValidationJournal of Medicinal Chemistry, 2008
- Second Generation Tetrahydroquinoline-Based Protein Farnesyltransferase Inhibitors as AntimalarialsJournal of Medicinal Chemistry, 2007
- Selective killing of the human malaria parasite Plasmodium falciparum by a benzylthiazolium dyeExperimental Parasitology, 2007
- Irreversible Inhibitors of Serine, Cysteine, and Threonine ProteasesChemical Reviews, 2002